| 1 |
33101775 | Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients. | 2020 Sep 30 |
1 |
| 2 |
27540594 | PD-1+ and Foxp3+ T cell reduction correlates with survival of HCC patients after sorafenib therapy. | 2016 Jul 21 |
2 |
| 3 |
24197135 | Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering. | 2014 Jan 1 |
3 |
| 4 |
23223899 | Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. | 2013 Apr |
2 |
| 5 |
18841360 | Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2. | 2009 Jun |
1 |